a-Bromo-gamma-butyrolactone
CAS: 5061-21-2
Ref. 3D-FB04489
25g | A consultar | |
50g | A consultar | |
100g | A consultar | |
250g | A consultar | |
500g | A consultar |
Información del producto
- 2-Bromo-4-hydroxybutyric acid-gamma-lactone
- (3R)-3-bromodihydrofuran-2(3H)-one
- (3S)-3-bromodihydrofuran-2(3H)-one
- 2(3H)-Furanone, 3-bromodihydro-
- 2-Bromo-4-Butanolide
- 2-Bromo-4-butyrolactone
- 2-Bromo-4-hydroxybutyric acid g-lactone
- 2-Bromo-4-hydroxybutyric acid gamma-lactone
- 2-Bromo-gamma-butyrolactone
- 2-Bromo-γ-butyrolactone
- Ver más sinónimos
- 3-Bromo-2-oxotetrahydrofuran
- 3-Bromo-4,5-dihydro-2(3H)-furanone
- 3-Bromodihydro-2(3H)-furanone
- 3-Bromooxolan-2-one
- 3-Bromotetrahydrofuran-2-one
- 3-bromodihydrofuran-2(3H)-one
- Butyric acid, 2-bromo-4-hydroxy-, γ-lactone
- Butyric acid, α-bromo-γ-hydroxy-, γ-lactone
- NSC 11726
- NSC 56959
- a-Bromo-γ-butyrolatone
- alfa-Bromo-gamma butyrolatone
- Α-Bromo-R-Butyrolactone
- α-Bromo-γ-butyrolactone
- α-Bromobutyric acid γ-lactone
a-Bromo-gamma-butyrolactone (BBAL) is a structural analog of gamma-hydroxybutyric acid, a drug used to treat narcolepsy and cataplexy. BBAL can be synthesized by reacting anhydrous sodium with a mixture of bromoacetic acid and acrylonitrile in the presence of potassium hydroxide. The reaction mechanism for this process is not fully understood but it is believed that a tautomerization may occur between the two possible structures: alpha and beta. This product has been shown to provide pain relief in animal models as well as improve symptoms of metabolic disorders such as diabetes mellitus type II.
Propiedades químicas
Consulta técnica sobre: 3D-FB04489 a-Bromo-gamma-butyrolactone
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.